AsCNP/JSNP/JSCNP 2019

講演情報

印刷

[AsCNP] シンポジウム

AsCNP » [AsCNP] シンポジウム

[AsCNP_S21] シンポジウム21
Translational Research for New Drug Development in Neuropsychiatric Disorders

2019年10月12日(土) 08:40 〜 10:20 第6会場 (401+402)

Organizer / Chair: Toshitaka NABESHIMA (Graduate School of Health Science, Fujita Health University, Japan), Co-chair: Yukihiro OHNO (Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan), Discussants: ‌Wen-Sung LAI (Department of Psychology, National Taiwan University, Taiwan), Ming-Huan CHAN (Institute of Neuroscience, National Chengchi University, Taiwan)

09:30 〜 09:54

[AsCNP-S21-3] Indoleamine-2,3-dioxygenase-1 is a molecular target for the protective activity of mood stabilizers against mania-like behavior induced by d-amphetamine

○Hyoung-Chun KIM1, Hai-Quyen TRAN1, Eun-Joo SHIN1, Kuniaki SAITO2, The-Vinh TRAN1, Naveen SHARMA1, Dae-Won KIM3, Soo Young CHOI4, Ji Hoon JEONG5, Choon-Gon JANG6, Toshitaka NABESHIMA2, 7, 8 (1. Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Korea, 2. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan, 3. Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung, Korea., 4. Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon, Korea, 5. Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Korea, 6. Department of Pharmacology, School of Pharmacy, Sungkyunkwan University Suwon, Korea, 7. Aino University, Ibaraki, Japan, 8. Japanese Drug Organization of Appropriate Use and Research, Nagoya, Japan)

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードは事前参加登録者へメール、および参加証に印字してお送りします。プログラム抄録集の「大会参加者へのご案内」にも掲載しております。

パスワード